TG Therapeutics News

TG Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Darwin Global Management, Ltd.(0%),Dr. Abhishek Trehan(0%), etc.

Nov 15 08:52

TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lonial Sagar

Nov 13 06:08

TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Charney Laurence N

Nov 13 06:05

TG Therapeutics | 144/A: Others

Nov 13 01:54

TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 13 00:38

TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 13 00:19

TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Echelard Yann

Nov 8 05:44

TG Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 8 05:38

TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 6 02:46

TG Therapeutics | 8-K: ® TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI (ublituximab-xiiy) Full Year Revenue Guidance

Nov 4 20:24

TG Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(14.2%)

Oct 8 05:11

TG Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 10 04:12

TG Therapeutics | 10-K/A: Annual report (Amendment)

Aug 10 04:03

TG Therapeutics | 8-K: ® TG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI (ublituximab-xiiy) Full Year Revenue Guidance

Aug 6 19:13

TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lonial Sagar

Jun 21 06:12

TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HUME DANIEL

Jun 21 06:12

TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hoberman Kenneth

Jun 21 06:07

TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Echelard Yann

Jun 21 06:07

TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Charney Laurence N

Jun 21 06:07

TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 21 05:08